273 related articles for article (PubMed ID: 28325727)
21. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Elphick H; Southern K
Cochrane Database Syst Rev; 2000; (4):CD002204. PubMed ID: 11034746
[TBL] [Abstract][Full Text] [Related]
22. Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis.
Armstead J; Morris J; Denning DW
PLoS One; 2014; 9(6):e98502. PubMed ID: 24914809
[TBL] [Abstract][Full Text] [Related]
23. Life-threatening allergic bronchopulmonary aspergillosis in a well child with cystic fibrosis.
Skowronski E; Fitzgerald DA
Med J Aust; 2005 May; 182(9):482-3. PubMed ID: 15865595
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis.
Ritz N; Ammann RA; Casaulta Aebischer C; Schoeni-Affolter F; Schoeni MH
Eur J Pediatr; 2005 Sep; 164(9):577-82. PubMed ID: 15926067
[TBL] [Abstract][Full Text] [Related]
25. Question 11: How should Allergic Bronchopulmonary Aspergillosis [ABPA] be managed in Cystic Fibrosis?
Ohn M; Robinson P; Selvadurai H; Fitzgerald DA
Paediatr Respir Rev; 2017 Sep; 24():35-38. PubMed ID: 27964950
[No Abstract] [Full Text] [Related]
26. Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis.
Koutsokera A; Corriveau S; Sykes J; Coriati A; Cortes D; Vadas P; Chaparro C; McIntyre K; Tullis E; Stephenson AL
J Cyst Fibros; 2020 Jan; 19(1):119-124. PubMed ID: 31405730
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry.
Kerem E; Viviani L; Zolin A; MacNeill S; Hatziagorou E; Ellemunter H; Drevinek P; Gulmans V; Krivec U; Olesen H;
Eur Respir J; 2014 Jan; 43(1):125-33. PubMed ID: 23598952
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for lung disease progression in children with cystic fibrosis.
van Horck M; van de Kant K; Winkens B; Wesseling G; Gulmans V; Hendriks H; van der Grinten C; Jöbsis Q; Dompeling E
Eur Respir J; 2018 Jun; 51(6):. PubMed ID: 29773689
[TBL] [Abstract][Full Text] [Related]
29. An investigation into biomarkers for the diagnosis of ABPA and aspergillus disease in cystic fibrosis.
Keown K; Abbott S; Kuzeljevic B; Rayment JH; Chilvers MA; Yang CL
Pediatr Pulmonol; 2019 Nov; 54(11):1787-1793. PubMed ID: 31359612
[TBL] [Abstract][Full Text] [Related]
30. Frequencies of pathogenic CFTR variants in Greek cystic fibrosis patients with allergic bronchopulmonary aspergillosis and Aspergillus fumigatus chronic colonization: A retrospective cohort study.
Noni M; Katelari A; Poulou M; Ioannidis D; Kapasouri EM; Tzetis M; Doudounakis SE; Kanaka-Gantenbein C; Spoulou V
J Mycol Med; 2023 Mar; 33(1):101326. PubMed ID: 36272381
[TBL] [Abstract][Full Text] [Related]
31. Treating Allergic Bronchopulmonary Aspergillosis with Short-Term Prednisone and Itraconazole in Cystic Fibrosis.
Gothe F; Schmautz A; Häusler K; Tran NB; Kappler M; Griese M
J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2608-2614.e3. PubMed ID: 32147521
[TBL] [Abstract][Full Text] [Related]
32. The basidiomycetous yeast Trichosporon may cause severe lung exacerbation in cystic fibrosis patients - clinical analysis of Trichosporon positive patients in a Munich cohort.
Kröner C; Kappler M; Grimmelt AC; Laniado G; Würstl B; Griese M
BMC Pulm Med; 2013 Nov; 13():61. PubMed ID: 24180379
[TBL] [Abstract][Full Text] [Related]
33. A multinational report on SARS-CoV-2 infection outcomes in people with CF and Aspergillus infection or ABPA.
Bradbury JD; Chesshyre E; Orenti A; Jung A; Warris A;
J Cyst Fibros; 2024 Mar; 23(2):354-363. PubMed ID: 37925255
[TBL] [Abstract][Full Text] [Related]
34. Diverse clinical characteristics of Aspergillus growth in patients with cystic fibrosis.
Emiralioğlu N; Doğru D; Doğan Ö; Gülmez D; Akdağlı SA; Polat SE; Tuğcu G; Hızal MG; Yalçın E; Özçelik U; Şener B; Kiper N
Turk J Pediatr; 2020; 62(4):560-568. PubMed ID: 32779408
[TBL] [Abstract][Full Text] [Related]
35. Serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis: State of the art and further challenges.
Delhaes L; Frealle E; Pinel C
Med Mycol; 2010 Nov; 48 Suppl 1():S77-87. PubMed ID: 21067334
[TBL] [Abstract][Full Text] [Related]
36. Diagnosing allergic bronchopulmonary aspergillosis in children with cystic fibrosis.
Thia LP; Balfour Lynn IM
Paediatr Respir Rev; 2009 Mar; 10(1):37-42. PubMed ID: 19203743
[TBL] [Abstract][Full Text] [Related]
37. Worsening pulmonary outcomes during sex reassignment therapy in a transgender female with cystic fibrosis (CF) and asthma/allergic bronchopulmonary aspergillosis: a case report.
Lam GY; Goodwin J; Wilcox P; Quon BS
BMC Pulm Med; 2020 Aug; 20(1):234. PubMed ID: 32867730
[TBL] [Abstract][Full Text] [Related]
38. [Allergic bronchopulmonary aspergillosis disclosing mucoviscidosis].
Coltey B; Pin I; Ferretti G; Bonadona A; Pison C; Brambilla C
Rev Mal Respir; 2001 Oct; 18(5):549-51. PubMed ID: 11887775
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody.
van der Ent CK; Hoekstra H; Rijkers GT
Thorax; 2007 Mar; 62(3):276-7. PubMed ID: 17329558
[TBL] [Abstract][Full Text] [Related]
40. Structural lung disease following allergic bronchopulmonary aspergillosis complicating pediatric cystic fibrosis.
McCashney A; Robinson P
Pediatr Pulmonol; 2021 Dec; 56(12):3737-3744. PubMed ID: 34427991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
